MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients

Biomarkers

Volumn 17, Issue 2, 2012, Pages 104-110

  Zhou, Hui ^a,c   Xiao, Bingxiu ^a   Zhou, Fei ^a   Deng, Hongxia ^a   Zhang, Xinjun ^a   Lou, Yanru ^a   Gong, Zhaohui ^a   Du, Caigan ^b   Guo, Junming ^a  

^a NINGBO UNIVERSITY   (China)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c First Hospital of Jiaxing   (China)

Author keywords

Circulating tumor cells; Gastric cancer; Gene diagnosis; MicroRNA 421; Tumor markers

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PATIENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PATIENT MONITORING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR GROWTH;

AGED; ANIMALS; CARCINOMA; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHINA; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; RIBONUCLEOTIDES; RNA, NEOPLASM; ROC CURVE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863250946     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2011.614961     Document Type: Article

References (35)

1. Bachtiar I, Santoso JM, Atmanegara B, Gani RA, Hasan I, Lesmana LA, Sulaiman A, Gu J, Tai S. (2009). Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta 399:97-101.
2. Bernard D, Martinez-Leal JF, Rizzo S, Martinez D, Hudson D, Visakorpi T, Peters G, Carnero A, Beach D, Gil J. (2005). CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene 24:5543-5551. (Pubitemid 43119349)
3. Cheng J, Guo JM, Xiao BX, Miao Y, Jiang Z, Zhou H, Li QN. (2011). piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin Chim Acta 412:1621-1625.
4. di Mario F, Cavallaro LG. (2008). Non-invasive tests in gastric diseases. Dig Liver Dis 40:523-530.
5. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, Benjamin H, Kushnir M, Cholakh H, Melamed N, Bentwich Z, Hod M, Goren Y, Chajut A. (2008). Serum microRNAs are promising novel biomarkers. Plos ONE 3:e3148.
6. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. (2009). Diferential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24:652-657.
7. Guo J, Xiao B, Zhang X, Jin Z, Chen J, Qin L, Mao X, Shen G, Chen H, Liu Z. (2004). Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers. J Mol Med 82:768-774. (Pubitemid 40022271)
8. Hao J, Zhang S, Zhou Y, Liu C, Hu X, Shao C. (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun 406:552-557.
9. Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. (2010). ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA 107:1506-1511.
10. Ikeguchi M, Kaibara N. (2005). Detection of circulating cancer cells after a gastrectomy for gastric cancer. Surg Today 35:436-441. (Pubitemid 40873804)
11. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y. (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45:17-23.
12. Kosaka N, Iguchi H, Ochiya T. (2010). Circulating microRNA in body fuid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 101:2087-2092.
13. Lurje G, Schiesser M, Claudius A, Schneider PM. (2010). Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol 2010:392652.
14. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 54:1696-1704.
15. Martínez-Arribas F, Agudo D, Pollán M, Gómez-Esquer F, Díaz-Gil G, Lucas R, Schneider J. (2006). Positive correlation between the expression of X-chromosome RBM genes (RBMX, RBM3, RBM10) and the proapoptotic Bax gene in human breast cancer. J Cell Biochem 97:1275-1282.
16. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518.
17. Miyazono F, Natsugoe S, Takao S, Tokuda K, Kijima F, Aridome K, Hokita S, Baba M, Eizuru Y, Aikou T. (2001). Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 233:189-194. (Pubitemid 32106072)
18. Nelson KM, Weiss GJ. (2008). MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ter 7:3655-3660.
19. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108. (Pubitemid 40372904)
20. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM. (2008). MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA 105:12885-12890.
21. Rohatgi PR, Yao JC, Hess K, Schnirer I, Rashid A, Mansfeld P F, Pisters PW, Ajani JA. (2006). Outcome of gastric cancer patients after successful gastrectomy: infuence of the type of recurrence and histology on survival. Cancer 107:2576-2580. (Pubitemid 44845610)
22. Sobin L, Wittekind C. (1997). International Union against Cancer. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. TNM classifcation of malignant tumours. 5th ed. New York: John Wiley, pp. 59-62.
23. Solcia E, Klöppel G, Sobin L, Williams E. (2000). Endocrine tumours of the gastrointestinal tract. In: Solcia E, editor. Histological typing of endocrine tumours. Berlin: Springer, pp. 61-68.
24. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69:1135-1142.
25. Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M. (2010). MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70:2339-2349.
26. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11:136-146.
27. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. (2010). Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 9:16.
28. Wang HJ, Ruan HJ, He XJ, Ma YY, Jiang XT, Xia YJ, Ye ZY, Tao HQ. (2010). MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46:2295-2303.
29. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z, Wang X, Fan D. (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2. Biochem Biophys Res Commun 392:340-345.
30. Xiao B, Guo J, Miao Y, Jiang Z, Huan R, Zhang Y, Li D, Zhong J. (2009). Detection of miR-106a in gastric carcinoma and its clinical signifcance. Clin Chim Acta 400:97-102.
31. Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu Z, Zhang M. (2010). MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 395:275-280.
32. Zhou H, Guo JM, Lou YR, Zhang XJ, Zhong FD, Jiang Z, Cheng J, Xiao BX. (2010). Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 88:709-717.
33. Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M, Li X. (2010a). MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. Febs J 277:3726-3734.
34. Zhu YM, Zhong ZX, Liu ZM. (2010b). Relationship between let-7a and gastric mucosa cancerization and its signifcance. World J Gastroenterol 16:3325-3329.
35. Zweig MH, Campbell G. (1993). Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577. (Pubitemid 23118304)